Delivery Order SPE2DR25D2007-SPE2DR26FM08A
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,033.08 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packaging). This firm fixed-price delivery order, issued on November 14, 2025, with an ultimate completion date of November 17, 2025, was competitively awarded without set-aside restrictions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Brilinta 90 mg tablets (60-count) valued at $2,535.30, with an ultimate completion date of September 26, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order for pharmaceutical supply. The contract was fulfilled by AmerisourceBergen's Corporate Office division, with performance taking place at the company's headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,451.98 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count units) under a firm fixed price contract. The award was made on August 4, 2025, with an ultimate completion date of August 5, 2025, and represents a non-competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $4,340.98 to AmerisourceBergen Drug Corp for the supply of Brilinta 60 mg tablets (60-count units) with a completion date of September 23, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Brilinta 60 mg tablets (60-count units) with a ceiling value of $4,769.52. This firm fixed price delivery order, with an ultimate completion date of July 21, 2025, represents a competitively awarded, non-set-aside contract utilizing AmerisourceBergen's existing pharmaceutical supply agreement. The order will be fulfilled from the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of BRILINTA 60 mg tablets (60-count units) under a firm fixed-price contract valued at $12,518.91. The order was competitively awarded without set-aside designation and is scheduled for completion by October 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,583.27 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count units). The contract was awarded on May 30, 2025, with an ultimate completion date of June 2, 2025, and represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,003.18 to AmerisourceBergen Drug Corp for the supply of Brilinta 60 mg tablets (60-count packages) under a Firm Fixed Price contract. The award was issued on November 14, 2025, with an ultimate completion date of November 17, 2025, and does not utilize a set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,415.32 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count package) under a firm fixed price contract. The award was issued on September 23, 2025, with an ultimate completion date of September 24, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location. This delivery order is unclassified as a set-aside and represents a competitive award within the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Brilinta 60 mg tablets (60-count units) valued at $1,211.20 under a firm fixed-price contract type. This delivery order, which is a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX, valued at $999.999 billion through December 2026), represents a competitively awarded, non-set-aside procurement. The place...
- SPE2DR25D2007Indefinite Delivery Contract
- SPE2DR25D2007-SPE2DR26FM08ADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 60 mg tablets (60-count units) under a firm fixed-price contract type. The order, valued at $2,230.62, was competitively awarded without set-aside designation and is scheduled for completion by November 5, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio with DLA demonstrates its critical role as a major pharmaceutical distributor serving Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 11/4/25 |